60 results on '"R. Lawes"'
Search Results
2. Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
- Author
-
A. Hunt, I. Hanson, A. Dunlop, H. Barnes, L. Bower, J. Chick, C. Cruickshank, E. Hall, T. Herbert, R. Lawes, D. McQuaid, H. McNair, A. Mitchell, J. Mohajer, T. Morgan, U. Oelfke, G. Smith, S. Nill, R. Huddart, and S. Hafeez
- Subjects
Adaptive radiotherapy ,bladder cancer ,MR-guided radiotherapy ,MR-linac ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Whole bladder magnetic resonance image-guided radiotherapy using the 1.5 Telsa MR-linac is feasible. Full online adaptive planning workflow based on the anatomy seen at each fraction was performed. This was delivered within 45 min. Intra-fraction bladder filling did not compromise target coverage. Patients reported acceptable tolerance of treatment.
- Published
- 2020
- Full Text
- View/download PDF
3. Graincast™: monitoring crop production across the Australian grainbelt
- Author
-
R. Lawes, Z. Hochman, E. Jakku, R. Butler, J. Chai, Y. Chen, F. Waldner, G. Mata, and R. Donohue
- Subjects
Plant Science ,Agronomy and Crop Science - Abstract
The Australian dryland grain-cropping landscape occupies 60 Mha. The broader agricultural sector (farmers and agronomic advisors, grain handlers, commodity forecasters, input suppliers, insurance providers) required information at many spatial and temporal scales. Temporal scales included hindcasts, nowcasts and forecasts, at spatial scales ranging from sub-field to the continent. International crop-monitoring systems could not service the need of local industry for digital information on crop production estimates. Therefore, we combined a broad suite of satellite-based crop-mapping, crop-modelling and data-delivery techniques to create an integrated analytics system (Graincast™) that covers the Australian cropping landscape. In parallel with technical developments, a set of user requirements was identified through a human-centred design process, resulting in an end-product that delivered a viable crop-monitoring service to industry. This integrated analytics solution can now produce crop information at scale and on demand and can deliver the output via an application programming interface. The technology was designed to underpin digital agriculture developments for Australia. End-users are now using crop-monitoring data for operational purposes, and we argue that a vertically integrated data supply chain is required to develop crop-monitoring technology further.
- Published
- 2022
4. Bovine TB infection status in cattle in Great Britain in 2020
- Author
-
Esl, Waller, A, Brouwer, P A, Upton, K A, Harris, J R, Lawes, D, Duncan, R, Avigad, and J, Dale
- Subjects
General Veterinary ,Animals ,Cattle Diseases ,Cattle ,General Medicine ,Tuberculosis, Bovine ,United Kingdom - Published
- 2022
5. OC-0465 A comparison of doctor and therapeutic radiographer (RTT) prostate contours on T2 weighted MRI
- Author
-
G. Smith, A. Dunlop, S. Alexander, H. Barnes, T. Herbert, R. Lawes, J. Murray, A. Pathmanathan, P. Patel, K. Sritharan, N. Sundahl, R. Westley, A. Tree, and H. McNair
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging ,Hematology - Published
- 2022
6. Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients
- Author
-
E. Carter, J. Murray, Helen McNair, R. Lawes, and M. Hussein
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Prostate ,medicine ,Humans ,Pelvic node ,Radiology, Nuclear Medicine and imaging ,education ,Lymph node ,Retrospective Studies ,education.field_of_study ,business.industry ,Radiotherapy Planning, Computer-Assisted ,Prostatic Neoplasms ,Soft tissue ,Radiotherapy Dosage ,medicine.disease ,Radiation therapy ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Lymph Nodes ,Radiotherapy, Intensity-Modulated ,Radiology ,Fiducial marker ,business - Abstract
Introduction Pelvic lymph nodes move independently to the prostate. When delivering radiotherapy to prostate and pelvic lymph nodes, daily inter- and intra-fraction anatomical changes need to be accounted for. Planning target volume (PTV) margins, grown from the pelvic lymph node clinical target volume need to be determined, to account for this variation in position. Methods Twenty patients who had daily online image guided radiotherapy to prostate and pelvic lymph nodes between April and December 2018 were selected. Ten pre-treatment verification images using cone beam CT from each patient were registered to pelvic bone anatomy, prostate soft tissue or fiducial markers and pelvic lymph node soft tissue to assess the accuracy of treatment delivery. Population systematic and random errors and PTV margins were calculated. Results PTV margins of 0.4 cm, 0.4 cm and 0.7 cm left–right (LR), superior–inferior (SI) and anterior–posterior (AP) respectively were derived for the pelvic lymph nodes when registering to prostate. PTV margins of 0.3 cm, 0.2 cm and 0.4 cm LR, SI and AP respectively were derived for the pelvic lymph nodes when registering to bone. There was a posterior systematic shift of the prostate during the treatment course. Conclusion There is differential motion of pelvic lymph nodes to prostate and in the era of prostate and pelvic radiotherapy for patients with node positive prostate cancer; there is increasing importance in the accuracy of dose delivery to the involved lymph node. Hence, this group of patients may benefit from personalised radiotherapy PTV margins, especially if the involved pelvic lymph node is within the anterior part of the clinical target volume. Implications for practice Optimisation of dose delivery to the pelvic lymph nodes when prioritising the prostate in prostate and pelvic lymph node image guided radiotherapy.
- Published
- 2021
7. Factors affecting accuracy and precision in ultrasound guided radiotherapy
- Author
-
Beverley Brigden, A. Gordon, Melanie Kerner, Emma J. Harris, Louise Delacroix, Georgina Aldis, Alexander Grimwood, Karen Thomas, Sally A Kember, Jane Francis, Helen McNair, Alison Tree, Emer Henegan, and R. Lawes
- Subjects
Accuracy and precision ,Observer (quantum physics) ,Image quality ,Computer science ,medicine.medical_treatment ,Image guidance ,R895-920 ,Residual ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Medical physics. Medical radiology. Nuclear medicine ,0302 clinical medicine ,Motion estimation ,Ultrasound ,medicine ,Radiology, Nuclear Medicine and imaging ,Computer vision ,Original Research Article ,RC254-282 ,Radiation ,Prostate cancer ,business.industry ,Treatment margins ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Ultrasound guided ,Radiation therapy ,030220 oncology & carcinogenesis ,Artificial intelligence ,Inter observer error ,business - Abstract
Background and purpose Transperineal ultrasound (TPUS) is used clinically for directly assessing prostate motion. Factors affecting accuracy and precision in TPUS motion estimation must be assessed to realise its full potential. Methods and materials Patients were imaged using volumetric TPUS during the Clarity-Pro trial (NCT02388308). Prostate motion was measured online at patient set-up and offline by experienced observers. Cone beam CT with markers was used as a comparator and observer performance was also quantified. The influence of different clinical factors was examined to establish specific recommendations towards efficacious ultrasound guided radiotherapy. Results From 330 fractions in 22 patients, offline observer random errors were 1.5 mm, 1.3 mm, 1.9 mm (left–right, superior-inferior, anteroposterior respectively). Errors increased in fractions exhibiting poor image quality to 3.3 mm, 3.3 mm and 6.8 mm. Poor image quality was associated with inconsistent probe placement, large anatomical changes and unfavourable imaging conditions within the patient. Online matching exhibited increased observer errors of: 3.2 mm, 2.9 mm and 4.7 mm. Four patients exhibited large systematic residual errors, of which three had poor quality images. Patient habitus showed no correlation with observer error, residual error, or image quality. Conclusions TPUS offers the unique potential to directly assess inter- and intra-fraction motion on conventional linacs. Inconsistent image quality, inexperienced operators and the pressures of the clinical environment may degrade precision and accuracy. Experienced operators are essential and cross-centre standards for training and QA should be established that build upon current guidance. Greater use of automation technologies may further minimise uncertainties.
- Published
- 2021
8. PD-0746 Single Institution Experience of Adjuvant Partial Breast Radiotherapy on the Elekta 1.5T MR Linac
- Author
-
I.Z. Tan, A. Mitchell, J. Chick, J. Sullivan, T. Morgan, R. Lawes, T. Herbert, H. McNair, and A.M. Kirby
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging ,Hematology - Published
- 2022
9. Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac
- Author
-
Jakob Ehlers, Cihan Gani, Toby Morgan, Helen McNair, P.K. Møller, Lorna Bower, S. Alexander, T. Herbert, H. Barnes, Neelam Tyagi, Baukelien van Triest, G. Smith, R. Lawes, Marlies E. Nowee, and Lee Whiteside
- Subjects
Patient experience ,medicine.medical_specialty ,R895-920 ,MR Linac ,MRI-guided ,030218 nuclear medicine & medical imaging ,Likert scale ,User confidence ,03 medical and health sciences ,Medical physics. Medical radiology. Nuclear medicine ,0302 clinical medicine ,Cronbach's alpha ,Content validity ,Medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Original Research Article ,Adaptive radiotherapy ,Treatment experience ,RC254-282 ,Mr linac ,business.industry ,Adaptive Radiotherapy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Oncology ,030220 oncology & carcinogenesis ,business - Abstract
Highlights • Questionnaires are important tools in assessing the tolerability of new technology. • Patient reported experience of treatment on the MR-Linac is consistently high. • The MR-Linac questionnaire has been validated as relevant and appropriate for use., Introduction With the implementation of new radiotherapy technology, it is imperative that patient experience is investigated alongside efficacy and outcomes. This paper presents the development of a specifically designed validated questionnaire and a first report of international multi-institutional preliminary patient experience of MRI-guided adaptive radiotherapy (MRgART) on the 1.5 T MR-Linac (MRL). Methods A patient experience questionnaire was developed and validated before being distributed to the Elekta MRL Consortium, to gather first patient-reported experience from participating centres worldwide. The final version of the questionnaire contains 18 questions covering a range of themes and was scored on a Likert scale of 0–3. Responses were post-processed so that a score of 0 represents a negative response and 3 represents the most favourable response. These results were analysed for patient-reported experience of treatment on the MRL. Results were also analysed for internal consistency of the questionnaire using Chronbach’s Alpha and the questionnaire contents were validated for relevance using content validity indexes (CVI). Results 170 responses were received from five centres, representing patients with a wide range of tumour treatment sites from four different countries. MRgART was well tolerated with an 84% favourable response across all questions and respondents. When analysed by theme, all reported the highest percentage of results in the favourable categories (2 and 3). Internal consistency in the questionnaire was high (Cronbach’s α = 0.8) and the item-level CVI for each question was 0.78 or above and the Scale-level CVI was 0.93, representing relevant content. Conclusion The developed questionnaire has been validated as relevant and appropriate for use in reporting experience of patients undergoing treatment on the MRL. The overall patient-reported experience and satisfaction from multiple centres within the Elekta MRL Consortium was consistently high. These results can reinforce user confidence in continuing to expand and develop MRL use in adaptive radiotherapy.
- Published
- 2021
10. Laser-free pelvic alignment in an online adaptive radiotherapy environment
- Author
-
Helen McNair, J. Mohajer, Alex Dunlop, T. Herbert, R. Lawes, H. Barnes, Alison Tree, and G. Smith
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,medicine.medical_specialty ,lcsh:R895-920 ,MR Linac ,Patient positioning ,lcsh:RC254-282 ,030218 nuclear medicine & medical imaging ,Short communications and technical note ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Adaptive radiotherapy ,Duration (project management) ,Care Planning ,Alignment ,Mr linac ,Oncology (nursing) ,business.industry ,Health Policy ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Longitudinal direction ,Laser-free ,Treatment modality ,030220 oncology & carcinogenesis ,business ,ART - Abstract
Highlights • The MR Linac is a novel laser-free online adaptive radiotherapy environment. • An audit of MR Linac pelvic set-up accuracy and time was conducted to establish a new standard of practice. • Pelvic patient positioning without calibrated lasers produces the level of accuracy required to perform online adaptive MR Linac treatments., The MR-Linac (MRL) provides a novel treatment modality that enables online adaptive treatments, but also creates new challenges for patient positioning in a laser-free environment. The accuracy and duration of prostate patient set-up on the MRL using two different methods for patient alignment was determined to establish standard of practice on the MRL. Differences in set-up accuracy were significant in the longitudinal direction and are accounted for in online plan adaption. Both methods recorded similar set-up times. The vendor recommended alignment method involves less manipulation of the patient and will be adopted as the standard positioning method for prostate and other pelvic patients on the MRL in future.
- Published
- 2020
11. Raw diets for dogs and cats: a review, with particular reference to microbiological hazards
- Author
-
J. R. Lawes, Robert Davies, and Andrew Wales
- Subjects
040301 veterinary sciences ,Raw feeding ,Review ,Cat Diseases ,0403 veterinary science ,Dogs ,Zoonoses ,Environmental health ,medicine ,Animals ,media_common.cataloged_instance ,Dog Diseases ,European union ,Raw meat ,Small Animals ,media_common ,biology ,business.industry ,0402 animal and dairy science ,04 agricultural and veterinary sciences ,biology.organism_classification ,medicine.disease ,040201 dairy & animal science ,Diet ,Europe ,Malnutrition ,Cats ,Food processing ,Listeria ,Brucella suis ,Livestock ,business - Abstract
There is a recent trend to feed pet dogs and cats in Britain and other developed countries on raw meat and animal by‐products using either commercial preparations or home recipes. This shift from heat‐treated processed food has been driven by perceived health benefits to pets and a suspicion of industrially produced pet food. The diets of wild‐living related species have been used as a rationale for raw feeding, but differences in biology and lifestyle impose limitations on such comparisons. Formal evidence does exist for claims by raw‐feeding proponents of an altered intestinal microbiome and (subjectively) improved stool quality. However, there is currently neither robust evidence nor identified plausible mechanisms for many of the wide range of other claimed benefits. There are documented risks associated with raw feeding, principally malnutrition (inexpert formulation and testing of diets) and infection affecting pets and/or household members. Surveys in Europe and North America have consistently found Salmonella species in a proportion of samples, typically of fresh‐frozen commercial diets. Another emerging issue concerns the risk of introducing antimicrobial‐resistant bacteria. Raw pet food commonly exceeds hygiene thresholds for counts of Enterobacteriaceae. These bacteria often encode resistance to critically important antibiotics such as extended‐spectrum cephalosporins, and raw‐fed pets create an elevated risk of shedding such resistant bacteria. Other infectious organisms that may be of concern include Listeria, shiga toxigenic E scherichia coli , parasites such as Toxoplasma gondii and exotic agents such as the zoonotic livestock pathogen Brucella suis, recently identified in European Union and UK raw pet meat imported from Argentina.
- Published
- 2019
12. Bovine TB infection status in cattle in Great Britain in 2017
- Author
-
L D, Perrin, K A, Harris, M, Reynolds, J R, Lawes, S, Frost, A, Brouwer, J, Dale, E, Palkopoulou, and P A, Upton
- Subjects
General Veterinary ,Incidence ,Animals ,Cattle ,General Medicine ,Sentinel Surveillance ,Tuberculosis, Bovine ,United Kingdom - Published
- 2019
13. PH-0164 Abdominal compression; development of a non-gated pancreas MRIgRT workflow
- Author
-
H. Barnes, H. Taylor, Uwe Oelfke, Andreas Wetscherek, G. Adair Smith, Simeon Nill, K. Aitken, A. Hunt, C. Lacey, R. Lawes, T. Herbert, R. Huddart, C. Ockwell, I. Hanson, S. Alexander, Helen McNair, and A. Mitchell
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,Workflow ,Oncology ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Radiology ,Abdominal compression ,Pancreas ,business - Published
- 2021
14. PD-0798 Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac
- Author
-
Neelam Tyagi, M. øller, G. Smith, T. Herbert, J. Ehlers, Helen McNair, H. Barnes, B. Van Triest, P. Krause, L. Bower, T. Morgan, Marlies E. Nowee, Cihan Gani, L. Whiteside, R. Lawes, and S. Alexander
- Subjects
medicine.medical_specialty ,Mr linac ,Oncology ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Hematology ,Treatment experience ,business - Published
- 2021
15. Bovine TB infection status in cattle inGreat Britain in 2018
- Author
-
D. Duncan, A. Brouwer, K. A. Harris, J. R. Lawes, R. Avigad, J. Dale, and P. A. Upton
- Subjects
General Veterinary ,Tuberculin Test ,Incidence ,Prevalence ,Animals ,Cattle ,General Medicine ,Mycobacterium bovis ,Sentinel Surveillance ,Tuberculosis, Bovine ,United Kingdom - Published
- 2020
16. Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
- Author
-
Ian Maddock Hanson, Alison Tree, E. Goodwin, H. Barnes, R. Lawes, Joan Chick, A. Mitchell, Uwe Oelfke, Rahul Nilawar, J. Mohajer, D. McQuaid, Alex Dunlop, A. Pathmanathan, Helen McNair, T. Herbert, Simeon Nill, Lorna Bower, and G. Smith
- Subjects
medicine.medical_treatment ,R895-920 ,Planning target volume ,MR-guided radiotherapy ,MR-linac ,Linear particle accelerator ,Article ,030218 nuclear medicine & medical imaging ,Medical physics. Medical radiology. Nuclear medicine ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Prostate ,medicine ,Radiology, Nuclear Medicine and imaging ,Adaptive radiotherapy ,RC254-282 ,Image-guided radiation therapy ,Mr linac ,business.industry ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Interfractional motion ,medicine.disease ,High-field MR-linac ,Radiation therapy ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Nuclear medicine ,business - Abstract
Highlights • MR-guided radiotherapy for prostate cancer can be delivered using a high filed MR-linac. • Comparison of estimated delivered dose between MR-guided adapted radiotherapy and conventional C-arm techniques. • MR-guided adaptive radiotherapy demonstrates improved target coverage for a subset of prostate cancer patients., Introduction MR-guided adapted radiotherapy (MRgART) using a high field MR-linac has recently become available. We report the estimated delivered fractional dose of the first five prostate cancer patients treated at our centre using MRgART and compare this to C-Arm linac daily Image Guided Radiotherapy (IGRT). Methods Patients were treated using adapted treatment plans shaped to their daily anatomy. The treatments were recalculated on an MR image acquired immediately prior to treatment delivery in order to estimate the delivered fractional dose. C-arm linac non-adapted VMAT treatment plans were recalculated on the same MR images to estimate the fractional dose that would have been delivered using conventional radiotherapy techniques using a daily IGRT protocol. Results 95% and 93% of mandatory target coverage objectives and organ at risk dose constraints were achieved by MRgART and C-arm linac delivered dose estimates, respectively. Both delivery techniques were estimated to have achieved 98% of mandatory Organ At Risk (OAR) dose constraints whereas for the target clinical goals, 86% and 80% were achieved by MRgART and C-arm linac delivered dose estimates. Conclusions Prostate MRgART can be delivered using the a high field MR-linac. Radiotherapy performed on a C-arm linac offers a good solution for prostate cancer patients who present with favourable anatomy at the time of reference imaging and demonstrate stable anatomy throughout the course of their treatment. For patients with critical OARs abutting target volumes on their reference image we have demonstrated the potential for a target dose coverage improvement for MRgART compared to C-arm linac treatment.
- Published
- 2019
17. PO-1766: A clinical solution for electron streaming shielding for partial breast treatments on Unity MRlinac
- Author
-
Uwe Oelfke, Anna M. Kirby, R. Lawes, Helen McNair, J. Chick, J. Sullivan, Maria A. Schmidt, T. Herbert, A. Mitchell, and Simeon Nill
- Subjects
Materials science ,Oncology ,Electromagnetic shielding ,Radiology, Nuclear Medicine and imaging ,Hematology ,Electron ,Molecular physics ,Partial breast - Published
- 2020
18. PO-1437: Treatment plan robustness analysis for high field MR-linac partial breast plans
- Author
-
T. Herbert, J. Mohajer, R.A. Mitchell, E. Goodwin, R. Lawes, Simeon Nill, Uwe Oelfke, Anna M. Kirby, Alex Dunlop, and J. Chick
- Subjects
High field mr ,Oncology ,Robustness (computer science) ,Computer science ,Treatment plan ,Control theory ,Radiology, Nuclear Medicine and imaging ,Hematology ,Linear particle accelerator ,Partial breast - Published
- 2020
19. OC-0469: MR-guided online adaptive radiotherapy for muscle invasive bladder cancer: First UK experience
- Author
-
R. Lawes, G. Smith, J. Mohajer, H. Barnes, J. Chick, L. Bower, Shaista Hafeez, A. Hunt, I. Hanson, Helen McNair, R. Huddart, Simeon Nill, T. Morgan, Uwe Oelfke, T. Herbert, Alex Dunlop, and A. Mitchell
- Subjects
medicine.medical_specialty ,Bladder cancer ,Oncology ,business.industry ,Muscle invasive ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Radiology ,Adaptive radiotherapy ,business ,medicine.disease ,Mri guided - Published
- 2020
20. MRI image acquisition on the MR-Linac for patients with locally advanced lung cancer (LALC)
- Author
-
R. Lawes, Fiona McDonald, Andreas Wetscherek, Sarah Brown, Michael Dubec, Corinne Faivre-Finn, H. Barnes, Anna-Maria Shiarli, D. Cobben, G. Smith, and T. Herbert
- Subjects
Pulmonary and Respiratory Medicine ,Cancer Research ,Mri image ,medicine.medical_specialty ,Mr linac ,Oncology ,business.industry ,Locally advanced ,Medicine ,Radiology ,business ,Lung cancer ,medicine.disease - Published
- 2020
21. MR Linac in practice: where are we now?
- Author
-
H. Barnes, Robert Huddart, S.A. Bhide, T. Herbert, Alison Tree, Helen McNair, Shaista Hafeez, G. Smith, I. Hanson, Simeon Nill, R. Lawes, and Sarah Helyer
- Subjects
Mr linac ,Computer science ,Radiology, Nuclear Medicine and imaging - Published
- 2020
22. PO-1828: Alignment of prostate cancer patients for radiotherapy on the MR-linac
- Author
-
Alex Dunlop, G. Adair Smith, H. Barnes, R. Lawes, Alison Tree, J. Mohajer, Helen McNair, and T. Herbert
- Subjects
Radiation therapy ,Prostate cancer ,Mr linac ,Oncology ,business.industry ,medicine.medical_treatment ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business ,medicine.disease ,Nuclear medicine - Published
- 2020
23. EP-2173 Bladder filling in patients undergoing prostate radiotherapy on the MR-linac
- Author
-
I. Hanson, D. McQuaid, H. Creasey, R. Huddart, Alex Dunlop, Helen McNair, Alison Tree, Uwe Oelfke, Simeon Nill, A. Mitchell, L. Bower, T. Herbert, G. Adair Smith, R. Lawes, and A. Pathmanathan
- Subjects
medicine.medical_specialty ,Mr linac ,Oncology ,business.industry ,Medicine ,Prostate radiotherapy ,Radiology, Nuclear Medicine and imaging ,In patient ,Hematology ,Radiology ,business ,Bladder filling - Published
- 2019
24. The PRISM Trial- First UK Experience of MRI-Guided Adaptive Radiotherapy
- Author
-
M. Ofuya, Robert Huddart, A. Mitchell, A. Pathmanathan, G. Smith, Chris Parker, Simeon Nill, R. Lawes, Alex Dunlop, D. McQuaid, Alison Tree, Helen McNair, I. Hanson, J. Rossan, T. Herbert, L. Bower, H. Creasey, Julia Murray, Uwe Oelfke, and Emma Hall
- Subjects
Cancer Research ,Radiation ,Oncology ,business.industry ,Optometry ,Medicine ,Radiology, Nuclear Medicine and imaging ,Prism ,Adaptive radiotherapy ,business ,Mri guided - Published
- 2019
25. EP-1566 MR-guided online adaptive radiotherapy: First experience in the UK
- Author
-
T. Herbert, A. Mitchell, R. Lawes, Alison Tree, Helen McNair, Alex Dunlop, G. Smith, H. Creasey, Emma Hall, A. Pathmanathan, D. McQuaid, L. Bower, R. Huddart, Simeon Nill, I. Hanson, and Uwe Oelfke
- Subjects
medicine.medical_specialty ,Oncology ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Radiology ,Adaptive radiotherapy ,business ,Mri guided - Published
- 2019
26. Defining Bowel and Nonsigmoid Bowel Dose Volume Constraints for Pelvic Radiation Therapy in GI Malignancies
- Author
-
C. Juman, Alexandra J. Stewart, R. Lawes, Sarah L. Gulliford, Jervoise Andreyev, S. Otter, Helen McNair, and Linda Wedlake
- Subjects
Cancer Research ,medicine.medical_specialty ,Radiation ,Oncology ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Radiology ,Dose volume constraints ,business ,Pelvic radiotherapy - Published
- 2018
27. Bovine TB surveillance in Great Britain in 2014
- Author
-
Adam Brouwer, Paul Upton, N. H. Smith, J. R. Lawes, Jennifer M. Broughan, and K. A. Harris
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Veterinary medicine ,Time Factors ,Genotyping Techniques ,040301 veterinary sciences ,Prevalence ,0403 veterinary science ,03 medical and health sciences ,Government Agencies ,Recurrence ,Environmental health ,Epidemiology ,medicine ,Animals ,General Veterinary ,business.industry ,Incidence (epidemiology) ,Incidence ,04 agricultural and veterinary sciences ,General Medicine ,United Kingdom ,030104 developmental biology ,Cattle ,Autopsy ,business ,Sentinel Surveillance ,Tuberculosis, Bovine ,Abattoirs - Abstract
This report, provided by the APHA, summarises the key descriptive epidemiological parameters of bovine TB in cattle in Great Britain from January 1 to December 31, 2014. It summarises some of the temporal trends observed over a longer period and highlights some differences and similarities between Scotland, Wales and the three bovine TB risk areas of England. It updates the previous annual summaries for 2012 and 2013, also published inVeterinary Record(VR, June 14, 2014, vol 174, pp 600-604; March 28, 2015, vol 176, pp 326-330).
- Published
- 2016
28. Strain typing of Mycoplasma cynos isolates from dogs with respiratory disease
- Author
-
Laura McAuliffe, J. R. Lawes, Joe Brownlie, Sally A. Mannering, and Kerstin Erles
- Subjects
DNA, Bacterial ,Male ,Kennel cough ,Mycoplasmataceae ,Microbiology ,Article ,Dogs ,Mycoplasma ,Species Specificity ,RAPD ,Mycoplasma cynos ,Pulsed-field gel electrophoresis ,Animals ,Mycoplasma Infections ,Dog Diseases ,Typing ,Respiratory Tract Infections ,DNA Primers ,General Veterinary ,biology ,Genetic heterogeneity ,Strain (biology) ,PFGE ,General Medicine ,biology.organism_classification ,Virology ,Electrophoresis, Gel, Pulsed-Field ,Random Amplified Polymorphic DNA Technique ,Trachea ,Mollicutes ,Female ,Canine infectious respiratory disease (CIRD) ,Bronchoalveolar Lavage Fluid - Abstract
The association of Mycoplasma cynos with canine infectious respiratory disease is increasingly being recognised. This study describes the strain typing of 14 M. cynos isolates cultured from trachea and bronchoalveolar lavage samples of six dogs with respiratory disease, from two separate kennels in the United Kingdom. The genetic similarity of the isolates was investigated using pulsed-field gel electrophoresis (PFGE) and random amplified polymorphic DNA (RAPD). Most of the isolates from four dogs housed at a re-homing kennel were genetically similar and some isolates from different dogs were indistinguishable by both PFGE and RAPD. These isolates were cultured from dogs with non-overlapping stays in the kennel, which may indicate maintenance of some strains within kennels. A small number of isolates showed much greater genetic heterogeneity and were genetically distinct from the main group of M. cynos strains. There was also a high degree of similarity of the M. cynos type strain (isolated from a dog with respiratory disease in Denmark in 1971) to at least one of the United Kingdom isolates using PFGE analysis, which may suggest possible conservation of pathogenic strains of M. cynos.
- Published
- 2009
29. The detection of Mycoplasma (formerly Eperythrozoon) wenyonii by 16S rDNA PCR and denaturing gradient gel electrophoresis
- Author
-
A. M. Barlow, Suzanna Bell, J. R. Lawes, Robin A.J. Nicholas, Laura McAuliffe, and Roger D. Ayling
- Subjects
DNA, Bacterial ,Time Factors ,Molecular Sequence Data ,Mycoplasmataceae ,medicine.disease_cause ,DNA, Ribosomal ,Polymerase Chain Reaction ,Sensitivity and Specificity ,Microbiology ,law.invention ,Mycoplasma ,Species Specificity ,law ,RNA, Ribosomal, 16S ,medicine ,Animals ,Mycoplasma Infections ,Ribosomal DNA ,Phylogeny ,Polymerase chain reaction ,Electrophoresis, Agar Gel ,Base Sequence ,General Veterinary ,biology ,fungi ,food and beverages ,General Medicine ,biology.organism_classification ,Anaplasmataceae ,Mollicutes ,Rickettsiales ,Temperature gradient gel electrophoresis - Abstract
Although the role of Mycoplasma wenyonii in disease is still subject to some debate, infections have been reported to result in parasitaemia, anaemia, scrotal and hind limb oedema, tachycardia, pyrexia, infertility, swollen teats, prefemoral lymphadenopathy and decreased milk production. Previously, diagnosis of M. wenyonii has been based on blood smears but is not specific for M. wenyonii and can be difficult to interpret. We have previously described the use of PCR and denaturing gradient gel electrophoresis (DGGE) for the detection and differentiation of Mycoplasma species. DGGE enables the rapid and specific identification of Mycoplasma species and is ideally suited to detecting both mixed infections and new and unusual species. In this study, we have used DGGE with universal primers to detect M. wenyonii DNA from blood samples. DGGE can be used on blood samples as a rapid and specific test for M. wenyonii and can also be used as a screening test for other blood borne pathogens.
- Published
- 2006
30. 16S rDNA PCR and denaturing gradient gel electrophoresis; a single generic test for detecting and differentiating Mycoplasma species
- Author
-
Laura McAuliffe, Richard J. Ellis, Robin A.J. Nicholas, Jo R. Lawes, and Roger D. Ayling
- Subjects
Electrophoresis ,Microbiology (medical) ,Mycoplasmataceae ,medicine.disease_cause ,DNA, Ribosomal ,Polymerase Chain Reaction ,Microbiology ,law.invention ,Mycoplasma ,law ,RNA, Ribosomal, 16S ,medicine ,Animals ,Humans ,Mycoplasma Infections ,Ribosomal DNA ,Polymerase chain reaction ,biology ,fungi ,food and beverages ,General Medicine ,biology.organism_classification ,16S ribosomal RNA ,Molecular biology ,Mollicutes ,Temperature gradient gel electrophoresis ,Bacteria - Abstract
Diagnosis of Mycoplasma infection is normally based on culture and serological tests, which can be time-consuming and laborious. A number of specific PCRs have been developed but to date there has not been a single generic test capable of detecting and differentiating mycoplasmas to a species level. This report describes the development of a new diagnostic test based on PCR of the 16S rRNA gene with Mycoplasma-specific primers and separation of the PCR product according to primary sequence using denaturing gradient gel electrophoresis (DGGE). DGGE enabled the differentiation of 67 Mycoplasma species of human and veterinary origin and represents a significant improvement on current tests as diagnosis of Mycoplasma infection can be made directly from clinical samples in less than 24 h.
- Published
- 2005
31. Performance characteristics and economic comparison of broiler chickens fed wheat- and triticale-based diets
- Author
-
D. R. Korver, Martin J. Zuidhof, and K. R. Lawes
- Subjects
Male ,Meat ,Live weight ,Broiler ,General Medicine ,Biology ,Triticale ,Weight Gain ,Feed conversion ratio ,Diet ,Eating ,Nutrient ,Animal science ,Carcass weight ,Costs and Cost Analysis ,Animals ,Animal Nutritional Physiological Phenomena ,Female ,Animal Science and Zoology ,Flock ,Edible Grain ,Chickens ,Triticum ,Barn (unit) - Abstract
The effects of triticale and wheat on broiler (mixed sexes) performance and cost of production were compared. In experiment 1, wheat- and triticale-based diets were fed to 3 strains of broilers (Ross x Ross, Hubbard x Hubbard, and Ross x Hubbard). Each of the diets was provided to 5 cages/strain (n = 10 chicks/cage; 1,273 cm2/bird). Weekly BW, gain, feed consumption, and feed conversion ratio (FCR; g of feed/g of gain) were determined. At 42 d, 4 chicks/pen were shipped to a commercial processing plant. The plucked, eviscerated carcasses were evaluated for carcass traits. Overall, the triticale-fed birds had lower final BW and average daily gain and higher FCR. Eviscerated carcass, thigh, and drum weights were lower, but pectoralis minor as a percentage of carcass weight was greater in triticale-fed birds. In experiment 2, a wheat diet and a diet in which triticale was substituted (by weight) for wheat were provided in a 3-phase feeding program. Each diet was provided to 2 identically-equipped commercial barns housing 17,034 broilers each. Individual BW of a sample of birds were recorded in each barn at 0, 19, 34, and 42 d, corresponding to the beginning and end of each dietary phase. Feed consumption and FCR were calculated for each barn. An analysis of each of the diets was calculated using a broiler chicken production cost model. Final BW, feed consumption, carcass weight at processing, flock uniformity, percentage of Grade A carcasses, and percentage of condemned carcasses were not affected by cereal source. Overall FCR (2.165, 2.036; P = 0.0052), feed cost (dollars 0.617, dollars 0.577/kg live weight; P = 0.0260), and total cost of production (dollars 1.019, dollars 0.972/kg live weight; P = 0.0183) were greater for the triticale than wheat diets, respectively. Triticale would be an economically feasible replacement for wheat in broiler diets when its price is less than or equal to 95% of the cost of wheat, less dollars 18 (Canadian). Increased knowledge of the available nutrient profile of triticale, as well as least-cost feed formulation would likely increase the value of triticale relative to wheat for broilers.
- Published
- 2004
32. Bayesian analysis of culture and PCR methods for detection of Campylobacter spp. in broiler caecal samples
- Author
-
J. D. Rodgers, E. M. Jones, J. R. Lawes, Ana Vidal, Mark Arnold, L. F. Powell, and Felicity A. Clifton-Hadley
- Subjects
DNA, Bacterial ,Veterinary medicine ,Epidemiology ,Population ,Biology ,medicine.disease_cause ,Diagnostic test evaluation ,Polymerase Chain Reaction ,Microbiology ,law.invention ,Feces ,law ,Campylobacter Infections ,medicine ,Animals ,education ,Polymerase chain reaction ,Poultry Diseases ,education.field_of_study ,Campylobacter ,Broiler ,Bayes Theorem ,Gold standard (test) ,Original Papers ,Infectious Diseases ,Campylobacter species ,Flock ,Chickens - Abstract
SUMMARYThe objective of this study was to estimate the sensitivity and specificity of a culture method and a polymerase chain reaction (PCR) method for detection of two Campylobacter species: C. jejuni and C. coli. Data were collected during a 3-year survey of UK broiler flocks, and consisted of parallel sampling of caeca from 436 batches of birds by both PCR and culture. Batches were stratified by season (summer/non-summer) and whether they were the first depopulation of the flock, resulting in four sub-populations. A Bayesian approach in the absence of a gold standard was adopted, and the sensitivity and specificity of the PCR and culture for each Campylobacter subtype was estimated, along with the true C. jejuni and C. coli prevalence in each sub-population. Results indicated that the sensitivity of the culture method was higher than that of PCR in detecting both species when the samples were derived from populations infected with at most one species of Campylobacter. However, from a mixed population, the sensitivity of culture for detecting both C. jejuni or C. coli is reduced while PCR is potentially able to detect both species, although the total probability of correctly identifying at least one species by PCR is similar to that of the culture method.
- Published
- 2014
33. Recent innovations in bipolar electrosurgery
- Author
-
S. P. Buysse, K. R. Lawes, J. S. Kennedy, and T. R. Ryan
- Subjects
Engineering ,medicine.medical_specialty ,Electrosurgery ,business.industry ,medicine.medical_treatment ,Forceps ,Energy delivery ,Single application ,Endoscopic surgery ,Surgery ,Reliability engineering ,Bipolar forceps ,medicine ,business ,Energy source ,Bipolar electrosurgery - Abstract
SummaryBipolar electrosurgery has been used routinely in endoscopic surgery since its inception and is associated with increased safety and precise energy delivery. The most common tool is the laparoscopic bipolar forceps. In the last decade, variations on this tool, along with other configurations, have been developed that expand the use of bipolar electrosurgery. These variations include bipolar hooks, needles, scissors, forceps with cutting capability and optimised instrument/energy source systems. These new technologies make bipolar electrosurgery a very versatile tool for haemostatic dissection in surgery. This paper reviews laparoscopic bipolar instruments and systems, including the advantages and limitations of each configuration. A new optimised forceps/generator system for surgical vessel-sealing, called the ‘LigaSure’ (Valleylab Inc., Boulder, CO, USA) vessel-sealing system is also discussed. The LigaSure system offers increased reliability with a single application and utility on a broader rang...
- Published
- 1999
34. Investigation of prevalence and risk factors for Campylobacter in broiler flocks at slaughter: results from a UK survey
- Author
-
Felicity A. Clifton-Hadley, L. F. Powell, R. Sayers, S. J. Evans, J. R. Lawes, J. D. Rodgers, Ana Vidal, and L. C. Snow
- Subjects
medicine.medical_specialty ,Veterinary medicine ,Epidemiology ,Biology ,medicine.disease_cause ,Campylobacter jejuni ,Animal science ,Risk Factors ,Campylobacter Infections ,medicine ,Prevalence ,Animals ,Significant risk ,Risk factor ,Poultry Diseases ,Campylobacter ,Broiler ,Odds ratio ,Survival Analysis ,United Kingdom ,Infectious Diseases ,Mortality level ,Flock ,Seasons ,Chickens ,Abattoirs - Abstract
SUMMARYDuring 2007–2009 a UK-wide, 3-year stratified randomized survey of UK chicken broiler flocks was conducted to estimate the prevalence ofCampylobacter-infected batches of birds at slaughter. Thirty-seven abattoirs, processing 88·3% of the total UK slaughter throughput, were recruited at the beginning of the survey. Of the 1174 slaughter batches sampled, 79·2% were found to be colonized withCampylobacter, the majority of isolates beingC. jejuni. Previous partial depopulation of the flock [odds ratio (OR) 5·21], slaughter in the summer months (categorized as June, July and August; OR 14·27) or autumn months (categorized as September, October and November; OR 1·70) increasing bird age (40–41 days, OR 3·18; 42–45 days, OR 3·56; ⩾46 days, OR 13·43) and higher recent mortality level in the flock (1·00–1·49% mortality, OR 1·57; ⩾1·49% mortality, OR 2·74) were all identified as significant risk factors forCampylobactercolonization of the birds at slaughter. Time in transit to the slaughterhouse of more than 2·5 h was identified as a protective factor (OR 0·52).
- Published
- 2012
35. The prevalence of Campylobacter spp. in broiler flocks and on broiler carcases, and the risks associated with highly contaminated carcases
- Author
-
L. F. Powell, J. D. Rodgers, Kate Harris, Felicity A. Clifton-Hadley, J. R. Lawes, Ana Vidal, and S. J. Evans
- Subjects
Veterinary medicine ,Epidemiology ,animal diseases ,Campylobacter coli ,Biology ,medicine.disease_cause ,Campylobacter jejuni ,Risk Factors ,Campylobacter Infections ,medicine ,Odds Ratio ,Prevalence ,Food microbiology ,Animals ,Significant risk ,Cecum ,Skin ,Campylobacter ,Broiler ,Odds ratio ,Baseline survey ,Contamination ,Original Papers ,United Kingdom ,Infectious Diseases ,Food Microbiology ,Flock ,Seasons ,Chickens ,Abattoirs - Abstract
SUMMARYA baseline survey on the prevalence of Campylobacter spp. in broiler flocks and Campylobacter spp. on broiler carcases in the UK was performed in 2008 in accordance with Commission Decision 2007/516/EC. Pooled caecal contents from each randomly selected slaughter batch, and neck and breast skin from a single carcase were examined for Campylobacter spp. The prevalence of Campylobacter in the caeca of broiler batches was 75·8% (303/400) compared to 87·3% (349/400) on broiler carcases. Overall, 27·3% of the carcases were found to be highly contaminated with Campylobacter (⩾1000 c.f.u./g). Slaughter in the summer months (June, July, August) [odds ratio (OR) 3·50], previous partial depopulation of the flock (OR 3·37), and an increased mortality at 14 days (⩾1·25% to Campylobacter-contaminated carcases. Four poultry companies and farm location were also found to be significantly associated with highly contaminated carcases.
- Published
- 2012
36. Layered, adhesively bonded hydroxyapatite coatings for orthopaedic implants
- Author
-
Samuel Lewin Evans, P.J. Gregson, and K. R. Lawes
- Subjects
chemistry.chemical_classification ,Materials science ,Biomedical Engineering ,Biophysics ,Bioengineering ,Polymer ,Finite element method ,Biomaterials ,chemistry ,Hydroxyapatite coating ,Forensic engineering ,Implant ,Composite material ,Interlocking - Abstract
A method of producing layered, adhesively bonded hydroxyapatite coatings is described. The coatings have a flexible polymeric interlayer which can improve load transfer from the implant to the bone, and a hydroxyapatite-rich surface which can provide mechanical interlocking with the bone. The coatings have been characterized using a number of methods including optical and electron microscopy, mechanical testing and finite element analysis. Some ways in which the coatings could be used to produce orthopaedic implants with improved mechanical and biological compatibility are discussed.
- Published
- 1994
37. VNTR analysis reveals unexpected genetic diversity within Mycoplasma agalactiae, the main causative agent of contagious agalactia
- Author
-
Roger D. Ayling, Colin P. Churchward, Guido Ruggero Loria, Laura McAuliffe, Robin A.J. Nicholas, and J. R. Lawes
- Subjects
Mycoplasma agalactiae ,ved/biology.organism_classification_rank.species ,lcsh:QR1-502 ,Minisatellite Repeats ,lcsh:Microbiology ,Intergenic region ,MYCOIDES SC ,Genetics ,Molecular Epidemiology ,MULTIPLE-LOCUS ,Goats ,11 Medical And Health Sciences ,Bacterial Typing Techniques ,Electrophoresis, Gel, Pulsed-Field ,Random Amplified Polymorphic DNA Technique ,Variable number tandem repeat ,DNA profiling ,MOLECULAR EPIDEMIOLOGIC ANALYSIS ,Life Sciences & Biomedicine ,Research Article ,Microbiology (medical) ,TANDEM REPEAT ANALYSIS ,DNA, Bacterial ,Genotype ,Hypothetical protein ,Sheep Diseases ,Biology ,Microbiology ,SEQUENCE ,mental disorders ,Pulsed-field gel electrophoresis ,FIELD GEL-ELECTROPHORESIS ,Animals ,Mycoplasma Infections ,Genetic diversity ,Science & Technology ,Goat Diseases ,Polymorphism, Genetic ,Sheep ,Molecular epidemiology ,IDENTIFICATION ,ved/biology ,DNA REPEATS ,06 Biological Sciences ,bacterial infections and mycoses ,DNA Fingerprinting ,ELEMENT ,bacteria ,07 Agricultural And Veterinary Sciences ,SDS-PAGE - Abstract
Background Mycoplasma agalactiae is the main cause of contagious agalactia, a serious disease of sheep and goats, which has major clinical and economic impacts. Previous studies of M. agalactiae have shown it to be unusually homogeneous and there are currently no available epidemiological techniques which enable a high degree of strain differentiation. Results We have developed variable number tandem repeat (VNTR) analysis using the sequenced genome of the M. agalactiae type strain PG2. The PG2 genome was found to be replete with tandem repeat sequences and 4 were chosen for further analysis. VNTR 5 was located within the hypothetical protein MAG6170 a predicted lipoprotein. VNTR 14 was intergenic between the hypothetical protein MAG3350 and the hypothetical protein MAG3340. VNTR 17 was intergenic between the hypothetical protein MAG4060 and the hypothetical protein MAG4070 and VNTR 19 spanned the 5' end of the pseudogene for a lipoprotein MAG4310 and the 3' end of the hypothetical lipoprotein MAG4320. We have investigated the genetic diversity of 88 M. agalactiae isolates of wide geographic origin using VNTR analysis and compared it with pulsed field gel electrophoresis (PFGE) and random amplified polymorphic DNA (RAPD) analysis. Simpson's index of diversity was calculated to be 0.324 for PFGE and 0.574 for VNTR analysis. VNTR analysis revealed unexpected diversity within M. agalactiae with 9 different VNTR types discovered. Some correlation was found between geographical origin and the VNTR type of the isolates. Conclusion VNTR analysis represents a useful, rapid first-line test for use in molecular epidemiological analysis of M. agalactiae for outbreak tracing and control.
- Published
- 2008
38. Use of spatiotemporal analysis of laboratory submission data to identify potential outbreaks of new or emerging diseases in cattle in Great Britain
- Author
-
J. R. Lawes, Ailsa Milnes, A. R. Sayers, Kieran Hyder, L. J. Hoinville, Alasdair J. C. Cook, and Alberto Vidal-Diez
- Subjects
medicine.medical_specialty ,Databases, Factual ,Cattle Diseases ,Early detection ,Disease ,Communicable Diseases, Emerging ,Disease Outbreaks ,Environmental health ,Paratuberculosis ,Epidemiology ,False positive paradox ,Animals ,Medicine ,Prospective Studies ,lcsh:Veterinary medicine ,General Veterinary ,business.industry ,Spatiotemporal Analysis ,Reproducibility of Results ,Outbreak ,General Medicine ,veterinary(all) ,United Kingdom ,Biotechnology ,Population Surveillance ,Space-Time Clustering ,Data quality ,lcsh:SF600-1100 ,Cattle ,business ,Research Article - Abstract
Background New and emerging diseases of livestock may impact animal welfare, trade and public health. Early detection of outbreaks can reduce the impact of these diseases by triggering control measures that limit the number of cases that occur. The aim of this study was to investigate whether prospective spatiotemporal methods could be used to identify outbreaks of new and emerging diseases in scanning surveillance data. SaTScan was used to identify clusters of unusually high levels of submissions where a diagnosis could not be reached (DNR) using different probability models and baselines. The clusters detected were subjected to a further selection process to reduce the number of false positives and a more detailed epidemiological analysis to ascertain whether they were likely to represent real outbreaks. Results 187,925 submissions of clinical material from cattle were made to the Regional Laboratory of the Veterinary Laboratories Agency (VLA) between 2002 and 2007, and the results were stored on the VLA FarmFile database. 16,925 of these were classified as DNRs and included in the analyses. Variation in the number and proportion of DNRs was found between syndromes and regions, so a spatiotemporal analysis for each DNR syndrome was done. Six clusters were identified using the Bernoulli model after applying selection criteria (e.g. size of cluster). The further epidemiological analysis revealed that one of the systemic clusters could plausibly have been due to Johne's disease. The remainder were either due to misclassification or not consistent with a single diagnosis. Conclusions Our analyses have demonstrated that spatiotemporal methods can be used to detect clusters of new or emerging diseases, identify clusters of known diseases that may not have been diagnosed and identify misclassification in the data, and highlighted the impact of data quality on the ability to detect outbreaks. Spatiotemporal methods should be used alongside current temporal methods for analysis of scanning surveillance data. These statistical analyses should be followed by further investigation of possible outbreaks to determine whether cases have common features suggesting that these are likely to represent real outbreaks, or whether issues with the collection or processing of information have resulted in false positives.
- Published
- 2011
39. Manufacturing costs for microsystems/MEMS using high aspect ratio microfabrication techniques.
- Author
-
R. Lawes
- Subjects
- *
SEMICONDUCTOR wafers , *MICROMACHINING , *SEMICONDUCTORS , *MICROFABRICATION - Abstract
Abstract The emphasis on high aspect ratio micromachining techniques for microsystems/MEMS has been mainly to achieve novel devices with, for example, high sensing or actuation performance. Often these utilize deep structures (100–1,000 μm) with vertical wall layers but with relatively modest spatial resolution (1–10 μm). As these techniques move from research to industrial manufacture, the capital cost of the equipment and the cost of device manufacture become important, particularly where more than one micromachining technique can meet the performance requirements. This paper investigates the layer-processing costs associated with the principal high aspect ratio micromachining techniques used in microsystems/MEMS fabrication, particularly silicon surface micromachining, wet bulk etching, wafer bonding, Deep Reactive Ion Etching, excimer laser micromachining, UV LIGA and X-ray LIGA. A cost model (MEMSCOST) has been developed which takes the financial, operational and machine-dependent parameters of the different manufacturing techniques as inputs and calculates the layer-processing costs at the wafer and chip level as a function of demand volume. The associated operational and investment costs are also calculated. Cost reductions through increases in the wafer size and decreases in chip area are investigated, and the importance of packaging costs demonstrated. [ABSTRACT FROM AUTHOR]
- Published
- 2007
40. Rapid monitoring of cropland primary productivity and shipping activity in Ukraine.
- Author
-
Wellington M, Kuhnert P, and Lawes R
- Subjects
- Ukraine, Food Supply, Crops, Agricultural, Edible Grain
- Abstract
Ukraine is an important global exporter of grain, especially to several countries with vulnerable food systems. The war in Ukraine may disrupt global food supply by limiting the planting, growth, and harvest of crops, or disrupting grain supply logistics. We apply a novel statistical modelling approach to satellite images of cropland in Ukraine for fast inference and exploration of cropping patterns and their influences in challenging environments. We also present satellite-derived cargo shipping activity as an accompaniment to these outputs to better explore the outcomes. Cropland Gross Primary Productivity in 2022 was 0.25gC/m2 lower than the 2010-2021 baseline period (p < 0.001). Similarly, cumulative annual cargo shipping activity ports in the Odesa and Mariupol regions were 45% and 62% lower in 2022 than in 2021, respectively. This suggests that cropland primary productivity has suffered during the conflict, and reliance on a few key port areas introduces vulnerability to the value chain., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Wellington et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
41. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
- Author
-
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Tree AC, Westley R, Williams B, and McNair HA
- Subjects
- Male, Humans, Prostate, Seminal Vesicles, Pelvis, Magnetic Resonance Imaging methods, Radiotherapy Planning, Computer-Assisted methods, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms radiotherapy, Radiotherapy, Image-Guided methods
- Abstract
Background and Purpose: The implementation of MRI-guided online adaptive radiotherapy has facilitated the extension of therapeutic radiographers' roles to include contouring, thus releasing the clinician from attending daily treatment. Following undergoing a specifically designed training programme, an online interobserver variability study was performed., Materials and Methods: 117 images from six patients treated on a MR Linac were contoured online by either radiographer or clinician and the same images contoured offline by the alternate profession. Dice similarity coefficient (DSC), mean distance to agreement (MDA), Hausdorff distance (HD) and volume metrics were used to analyse contours. Additionally, the online radiographer contours and optimised plans (n = 59) were analysed using the offline clinician defined contours. After clinical implementation of radiographer contouring, target volume comparison and dose analysis was performed on 20 contours from five patients., Results: Comparison of the radiographers' and clinicians' contours resulted in a median (range) DSC of 0.92 (0.86 - 0.99), median (range) MDA of 0.98 mm (0.2-1.7) and median (range) HD of 6.3 mm (2.5-11.5) for all 117 fractions. There was no significant difference in volume size between the two groups. Of the 59 plans created with radiographer online contours and overlaid with clinicians' offline contours, 39 met mandatory dose constraints and 12 were acceptable because 95 % of the high dose PTV was covered by 95 % dose, or the high dose PTV was within 3 % of online plan. A clinician blindly reviewed the eight remaining fractions and, using trial quality assurance metrics, deemed all to be acceptable. Following clinical implementation of radiographer contouring, the median (range) DSC of CTV was 0.93 (0.88-1.0), median (range) MDA was 0.8 mm (0.04-1.18) and HD was 5.15 mm (2.09-8.54) respectively. Of the 20 plans created using radiographer online contours overlaid with clinicians' offline contours, 18 met the dosimetric success criteria, the remaining 2 were deemed acceptable by a clinician., Conclusion: Radiographer and clinician prostate and seminal vesicle contours on MRI for an online adaptive workflow are comparable and produce clinically acceptable plans. Radiographer contouring for prostate treatment on a MR-linac can be effectively introduced with appropriate training and evaluation. A DSC threshold for target structures could be implemented to streamline future training., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr Helen A McNair reports financial support was provided by National Institute for Health Research and Health Education England. Alison Tree, Angela Pathmanathan, Rosalyne Westley reports a relationship with Elekta Ltd. Alison Tree reports a relationship with Accuray Inc. Alison Tree reports a relationship with Varian Medical Systems Inc. Alison Tree, Sophie Alexander reports a relationship with Cancer Research UK that. Research at The Institute of Cancer Research is also supported by Cancer Research UK under Programme C33589/A28284 and C7224/A28724.., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. "I am not a Good Woman?" Exploring the Views and Challenges of Nurses When Discussing HPV Testing and Associated Cervical Screening with Women in Iraq.
- Author
-
Ali SM, Lawes R, and Ghalib AK
- Abstract
Introduction: Cervical cancer is mostly caused by high-risk Human papillomavirus HPV, with an estimation prevalence of HPV of 99.7% worldwide. The US Food and Drug Administration (FDA) approved an HPV test for primary cervical screening in 2014. An HPV-DNA test, which provides higher protection against invasive cervical carcinomas, is replacing the long-standing Pap smear as the primary method of cervical cancer screening., Objective: To explore nurses' experience and knowledge of HPV DNA testing and how screening impacts on women's health through increasing awareness and proposing actions for health education strategies., Method: A qualitative exploratory study was conducted on a purposeful sample of 25 qualified nurses, who were all employed in regional hospitals within a gynecological department in Kirkuk, Iraq. The nurses were interviewed with a semi-structured topic guide between November 2021 and February 2022. Responses were transcribed verbatim, translated into English and analysed using a content thematic analysis approach., Results: Four themes with associated sub-themes emerged following coding and peer review. Participants had lack of experience and fragmented knowledge of HPV DNA testing/screening. Culturally sensitive resources for patients and training for nurses was identified key requirements., Conclusions: Currently, there are no facilities for a HPV testing/screening services available in Iraq. The role of nurses undertaking HPV screening is not established and yet nurses represent the largest sector of health professionals. The dissemination of a collaborative HPV screening training programme to include clinical competence and knowledge for nurses and gynaecologists may improve knowledge, and could also be effective in improving patient awareness and engagement with cervical health., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
43. Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI.
- Author
-
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Westley R, Tree AC, and McNair HA
- Abstract
The implementation of MRI-guided online adaptive radiotherapy has enabled extension of therapeutic radiographers' roles to include contouring. An offline interobserver variability study compared five radiographers' and five clinicians' contours on 10 MRIs acquired on a MR-Linac from 10 patients. All contours were compared to a "gold standard" created from an average of clinicians' contours. The median (range) DSC of radiographers' and clinicians' contours compared to the "gold standard" was 0.91 (0.86-0.96), and 0.93 (0.88-0.97) respectively illustrating non-inferiority of the radiographers' contours to the clinicians. There was no significant difference in HD, MDA or volume size between the groups., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr Helen A McNair reports financial support was provided by National Institute for Health Research and Health Education England. Alison Tree, Angela Pathmanathan, Rosalyne Westley reports a relationship with Elekta Ltd. Alison Tree reports a relationship with Accuray Inc. Alison Tree reports a relationship with Varian Medical Systems Inc. Alison Tree, Sophie Alexander reports a relationship with Cancer Research UK that. Research at The Institute of Cancer Research is also supported by Cancer Research UK under Programme C33589/A28284 and C7224/A28724., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?
- Author
-
Lawes R, Barnes H, Herbert T, Mitchell A, Nill S, Oelfke U, Pathmanathan A, Smith GA, Sritharan K, Tree A, McNair HA, and Dunlop A
- Abstract
A shift of the daily plan can mitigate target position changes that occur between daily MR acquisition and treatment for MR-linac radiotherapy, but increases the session time. We demonstrated that our workflow strategy and decision-making process, to determine whether a subsequent shift is necessary, is appropriate., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Alison Tree acknowledges research funding from Elekta, Varian and Accuray and honoraria/travel grants from Elekta, Accuray and Janssen. Angela Pathmanathan acknowledges honoraria from Elekta and Janssen. ICR/RMH is a member of the Elekta MR-linac Research Consortium and receives institutional support from Elekta., (© 2022 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.)
- Published
- 2022
- Full Text
- View/download PDF
45. Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: The dosimetric impact.
- Author
-
Smith GA, Dunlop A, Barnes H, Herbert T, Lawes R, Mohajer J, Tree AC, and McNair HA
- Abstract
The implementation of adaptive radiotherapy for prostate cancer compensates for inter-fraction motion, at the penalty of increased time in room. The subsequent increase in bladder filling may impact dosimetry, which we have investigated on ten patients treated on the MR-linac. Patients drank water before treatment, to achieve a bladder volume of 200-300 cm
3 . Bladder and bowel were re-outlined offline on 140 images and plans recalculated. All mandatory bladder dose constraints and 99.1% of bowel constraints were achieved at time of treatment, despite varying bladder volumes and varying adherence to original bladder filling guidance., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This report is independent research supported by the National Institute for Health Research and Health Education England (HEE/ NIHR ICA Programme Senior Clinical Lectureship, Dr Helen McNair, ICA-SCL-2018-04-ST2-002). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. We also acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research. AT acknowledges support from The Rosetrees Trust. The Institute of Cancer Research is supported by Cancer Research UK Programme Grants (C33589/A19727, C33589/A19908 and C33589/A28284). ICR/RMH is a member of the Elekta MR Linac Research Consortium and receives institutional support from Elekta. Dr. Tree reports grants and other from Elekta, during the conduct of the study; grants from Accuray, grants from Varian, other from Genesis Healthcare, outside the submitted work., (© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.)- Published
- 2022
- Full Text
- View/download PDF
46. Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac.
- Author
-
Barnes H, Alexander S, Bower L, Ehlers J, Gani C, Herbert T, Lawes R, Møller PK, Morgan T, Nowee ME, Smith G, van Triest B, Tyagi N, Whiteside L, and McNair H
- Abstract
Introduction: With the implementation of new radiotherapy technology, it is imperative that patient experience is investigated alongside efficacy and outcomes. This paper presents the development of a specifically designed validated questionnaire and a first report of international multi-institutional preliminary patient experience of MRI-guided adaptive radiotherapy (MRgART) on the 1.5 T MR-Linac (MRL)., Methods: A patient experience questionnaire was developed and validated before being distributed to the Elekta MRL Consortium, to gather first patient-reported experience from participating centres worldwide. The final version of the questionnaire contains 18 questions covering a range of themes and was scored on a Likert scale of 0-3. Responses were post-processed so that a score of 0 represents a negative response and 3 represents the most favourable response. These results were analysed for patient-reported experience of treatment on the MRL. Results were also analysed for internal consistency of the questionnaire using Chronbach's Alpha and the questionnaire contents were validated for relevance using content validity indexes (CVI)., Results: 170 responses were received from five centres, representing patients with a wide range of tumour treatment sites from four different countries. MRgART was well tolerated with an 84% favourable response across all questions and respondents. When analysed by theme, all reported the highest percentage of results in the favourable categories (2 and 3). Internal consistency in the questionnaire was high (Cronbach's α = 0.8) and the item-level CVI for each question was 0.78 or above and the Scale-level CVI was 0.93, representing relevant content., Conclusion: The developed questionnaire has been validated as relevant and appropriate for use in reporting experience of patients undergoing treatment on the MRL. The overall patient-reported experience and satisfaction from multiple centres within the Elekta MRL Consortium was consistently high. These results can reinforce user confidence in continuing to expand and develop MRL use in adaptive radiotherapy., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
47. Factors affecting accuracy and precision in ultrasound guided radiotherapy.
- Author
-
Grimwood A, Thomas K, Kember S, Aldis G, Lawes R, Brigden B, Francis J, Henegan E, Kerner M, Delacroix L, Gordon A, Tree A, Harris EJ, and McNair HA
- Abstract
Background and Purpose: Transperineal ultrasound (TPUS) is used clinically for directly assessing prostate motion. Factors affecting accuracy and precision in TPUS motion estimation must be assessed to realise its full potential., Methods and Materials: Patients were imaged using volumetric TPUS during the Clarity-Pro trial (NCT02388308). Prostate motion was measured online at patient set-up and offline by experienced observers. Cone beam CT with markers was used as a comparator and observer performance was also quantified. The influence of different clinical factors was examined to establish specific recommendations towards efficacious ultrasound guided radiotherapy., Results: From 330 fractions in 22 patients, offline observer random errors were 1.5 mm, 1.3 mm, 1.9 mm (left-right, superior-inferior, anteroposterior respectively). Errors increased in fractions exhibiting poor image quality to 3.3 mm, 3.3 mm and 6.8 mm. Poor image quality was associated with inconsistent probe placement, large anatomical changes and unfavourable imaging conditions within the patient. Online matching exhibited increased observer errors of: 3.2 mm, 2.9 mm and 4.7 mm. Four patients exhibited large systematic residual errors, of which three had poor quality images. Patient habitus showed no correlation with observer error, residual error, or image quality., Conclusions: TPUS offers the unique potential to directly assess inter- and intra-fraction motion on conventional linacs. Inconsistent image quality, inexperienced operators and the pressures of the clinical environment may degrade precision and accuracy. Experienced operators are essential and cross-centre standards for training and QA should be established that build upon current guidance. Greater use of automation technologies may further minimise uncertainties., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alison Tree reports support from Elekta, Varian and Accuray as a clinical research fellow working on other projects (not related to this project) and personally has received honoraria and travel grants from Elekta to cover meeting attendance. Emma Harris reports a non-financial research agreement with Elekta from 2014 until 2017 covering support and advice for the trial from which this study’s data was generated. A current research framework agreement between ICR and Elekta Ltd. is also reported, which does not pertain to this study. All other authors have no competing interests to declare., (© 2021 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.)
- Published
- 2021
- Full Text
- View/download PDF
48. Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients.
- Author
-
Lawes R, Carter E, Hussein M, Murray J, and McNair HA
- Subjects
- Humans, Lymph Nodes diagnostic imaging, Male, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Retrospective Studies, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms radiotherapy, Radiotherapy, Intensity-Modulated
- Abstract
Introduction: Pelvic lymph nodes move independently to the prostate. When delivering radiotherapy to prostate and pelvic lymph nodes, daily inter- and intra-fraction anatomical changes need to be accounted for. Planning target volume (PTV) margins, grown from the pelvic lymph node clinical target volume need to be determined, to account for this variation in position., Methods: Twenty patients who had daily online image guided radiotherapy to prostate and pelvic lymph nodes between April and December 2018 were selected. Ten pre-treatment verification images using cone beam CT from each patient were registered to pelvic bone anatomy, prostate soft tissue or fiducial markers and pelvic lymph node soft tissue to assess the accuracy of treatment delivery. Population systematic and random errors and PTV margins were calculated., Results: PTV margins of 0.4 cm, 0.4 cm and 0.7 cm left-right (LR), superior-inferior (SI) and anterior-posterior (AP) respectively were derived for the pelvic lymph nodes when registering to prostate. PTV margins of 0.3 cm, 0.2 cm and 0.4 cm LR, SI and AP respectively were derived for the pelvic lymph nodes when registering to bone. There was a posterior systematic shift of the prostate during the treatment course., Conclusion: There is differential motion of pelvic lymph nodes to prostate and in the era of prostate and pelvic radiotherapy for patients with node positive prostate cancer; there is increasing importance in the accuracy of dose delivery to the involved lymph node. Hence, this group of patients may benefit from personalised radiotherapy PTV margins, especially if the involved pelvic lymph node is within the anterior part of the clinical target volume., Implications for Practice: Optimisation of dose delivery to the pelvic lymph nodes when prioritising the prostate in prostate and pelvic lymph node image guided radiotherapy., Competing Interests: Conflict of interest statement None., (Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
49. Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.
- Author
-
Hunt A, Hanson I, Dunlop A, Barnes H, Bower L, Chick J, Cruickshank C, Hall E, Herbert T, Lawes R, McQuaid D, McNair H, Mitchell A, Mohajer J, Morgan T, Oelfke U, Smith G, Nill S, Huddart R, and Hafeez S
- Abstract
Whole bladder magnetic resonance image-guided radiotherapy using the 1.5 Telsa MR-linac is feasible. Full online adaptive planning workflow based on the anatomy seen at each fraction was performed. This was delivered within 45 min. Intra-fraction bladder filling did not compromise target coverage. Patients reported acceptable tolerance of treatment., Competing Interests: The Royal Marsden Hospital and the Institute of Cancer Research are members of the Elekta MR-linac Consortium, which aims to coordinate international collaborative research relating to the Elekta Unity (MR-linac). Elekta (Elekta AB, Stockholm, Sweden) and Philips (Philips, Best, Netherlands) are commercial members of the MR-linac Consortium. Elekta financially supports consortium member institutions with research funding, education, and travel costs for consortium meetings. No commercial financial support was received from any organisation for the submitted work. AH, IH, AD, HB, LB, JC, CC, TH, RL, DM, HM, AM, JM, GS, and SN, have no other conflicts to disclose. HM also reports grant funding from a National Institute for Health Research and Health Education England (NIHR & HEE), Senior Clinical Lecturer award. TM also reports grant from Lister Institute of Preventive Medicine, outside the submitted work. EH is supported by a Cancer Research UK Centres Network Accelerator Award Grant (A21993) to the ART-NET consortium, other grants from Cancer Research UK during the conduct of the study; grants from Accuray Inc., grants from Varian Medical Systems Inc., outside the submitted work. UO also reports grants from Cancer Research UK. RH also reports non-financial support from Janssen, grants and personal fees from MSD, personal fees from Bristol Myers Squibb, grants from Cancer Research UK, other from Nektar Therapeutics, personal fees and non-financial support from Roche outside the submitted work. SH also reports non-financial support from Merck Sharp & Dohme (MSD), personal fees and non-financial support from Roche outside the submitted work., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
50. Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac.
- Author
-
Dunlop A, Mitchell A, Tree A, Barnes H, Bower L, Chick J, Goodwin E, Herbert T, Lawes R, McNair H, McQuaid D, Mohajer J, Nilawar R, Pathmanathan A, Smith G, Hanson I, Nill S, and Oelfke U
- Abstract
Introduction: MR-guided adapted radiotherapy (MRgART) using a high field MR-linac has recently become available. We report the estimated delivered fractional dose of the first five prostate cancer patients treated at our centre using MRgART and compare this to C-Arm linac daily Image Guided Radiotherapy (IGRT)., Methods: Patients were treated using adapted treatment plans shaped to their daily anatomy. The treatments were recalculated on an MR image acquired immediately prior to treatment delivery in order to estimate the delivered fractional dose. C-arm linac non-adapted VMAT treatment plans were recalculated on the same MR images to estimate the fractional dose that would have been delivered using conventional radiotherapy techniques using a daily IGRT protocol., Results: 95% and 93% of mandatory target coverage objectives and organ at risk dose constraints were achieved by MRgART and C-arm linac delivered dose estimates, respectively. Both delivery techniques were estimated to have achieved 98% of mandatory Organ At Risk (OAR) dose constraints whereas for the target clinical goals, 86% and 80% were achieved by MRgART and C-arm linac delivered dose estimates., Conclusions: Prostate MRgART can be delivered using the a high field MR-linac. Radiotherapy performed on a C-arm linac offers a good solution for prostate cancer patients who present with favourable anatomy at the time of reference imaging and demonstrate stable anatomy throughout the course of their treatment. For patients with critical OARs abutting target volumes on their reference image we have demonstrated the potential for a target dose coverage improvement for MRgART compared to C-arm linac treatment., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.